• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global infantile spasms therapeutics market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global infantile spasms therapeutics market 2018 – 2022 ($ million)
o 4.2 Route of Administration Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Route of Administration Segment 2018 – 2022 ($ million)
o 4.3 Drug Class Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Route of Administration – Market share 2023-2028 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Parenteral – Market size and forecast 2023-2028
o Exhibit 34: Chart on Parenteral – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Parenteral – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Parenteral – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Parenteral – Year-over-year growth 2023-2028 (%)
o 6.4 Oral – Market size and forecast 2023-2028
o Exhibit 38: Chart on Oral – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Oral – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Oral – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Oral – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Drug Class
o 7.1 Market segments
o Exhibit 44: Chart on Drug Class – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Drug Class – Market share 2023-2028 (%)
o 7.2 Comparison by Drug Class
o Exhibit 46: Chart on Comparison by Drug Class
o Exhibit 47: Data Table on Comparison by Drug Class
o 7.3 Anticonvulsants – Market size and forecast 2023-2028
o Exhibit 48: Chart on Anticonvulsants – Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Anticonvulsants – Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Anticonvulsants – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Anticonvulsants – Year-over-year growth 2023-2028 (%)
o 7.4 Corticosteroids – Market size and forecast 2023-2028
o Exhibit 52: Chart on Corticosteroids – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Corticosteroids – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Corticosteroids – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Corticosteroids – Year-over-year growth 2023-2028 (%)
o 7.5 Others – Market size and forecast 2023-2028
o Exhibit 56: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Drug Class
o Exhibit 60: Market opportunity by Drug Class ($ million)
o Exhibit 61: Data Table on Market opportunity by Drug Class ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 67: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 83: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 91: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 France – Market size and forecast 2023-2028
o Exhibit 95: Chart on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.11 China – Market size and forecast 2023-2028
o Exhibit 99: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Amneal Pharmaceuticals Inc.
o Exhibit 111: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 112: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 113: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 114: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 115: Amneal Pharmaceuticals Inc. – Segment focus
o 12.4 Cipla Ltd.
o Exhibit 116: Cipla Ltd. – Overview
o Exhibit 117: Cipla Ltd. – Business segments
o Exhibit 118: Cipla Ltd. – Key news
o Exhibit 119: Cipla Ltd. – Key offerings
o Exhibit 120: Cipla Ltd. – Segment focus
o 12.5 Endo International Plc
o Exhibit 121: Endo International Plc – Overview
o Exhibit 122: Endo International Plc – Business segments
o Exhibit 123: Endo International Plc – Key news
o Exhibit 124: Endo International Plc – Key offerings
o Exhibit 125: Endo International Plc – Segment focus
o 12.6 H Lundbeck AS
o Exhibit 126: H Lundbeck AS – Overview
o Exhibit 127: H Lundbeck AS – Product / Service
o Exhibit 128: H Lundbeck AS – Key offerings
o 12.7 Hetero Labs Ltd.
o Exhibit 129: Hetero Labs Ltd. – Overview
o Exhibit 130: Hetero Labs Ltd. – Product / Service
o Exhibit 131: Hetero Labs Ltd. – Key offerings
o 12.8 Intas Pharmaceuticals Ltd.
o Exhibit 132: Intas Pharmaceuticals Ltd. – Overview
o Exhibit 133: Intas Pharmaceuticals Ltd. – Product / Service
o Exhibit 134: Intas Pharmaceuticals Ltd. – Key offerings
o 12.9 Jazz Pharmaceuticals Plc
o Exhibit 135: Jazz Pharmaceuticals Plc – Overview
o Exhibit 136: Jazz Pharmaceuticals Plc – Product / Service
o Exhibit 137: Jazz Pharmaceuticals Plc – Key news
o Exhibit 138: Jazz Pharmaceuticals Plc – Key offerings
o 12.10 Mallinckrodt Plc
o Exhibit 139: Mallinckrodt Plc – Overview
o Exhibit 140: Mallinckrodt Plc – Business segments
o Exhibit 141: Mallinckrodt Plc – Key offerings
o Exhibit 142: Mallinckrodt Plc – Segment focus
o 12.11 Marinus Pharmaceuticals Inc.
o Exhibit 143: Marinus Pharmaceuticals Inc. – Overview
o Exhibit 144: Marinus Pharmaceuticals Inc. – Product / Service
o Exhibit 145: Marinus Pharmaceuticals Inc. – Key offerings
o 12.12 MSN Laboratories
o Exhibit 146: MSN Laboratories – Overview
o Exhibit 147: MSN Laboratories – Product / Service
o Exhibit 148: MSN Laboratories – Key offerings
o 12.13 Ovid Therapeutics Inc.
o Exhibit 149: Ovid Therapeutics Inc. – Overview
o Exhibit 150: Ovid Therapeutics Inc. – Product / Service
o Exhibit 151: Ovid Therapeutics Inc. – Key offerings
o 12.14 Sanofi SA
o Exhibit 152: Sanofi SA – Overview
o Exhibit 153: Sanofi SA – Business segments
o Exhibit 154: Sanofi SA – Key news
o Exhibit 155: Sanofi SA – Key offerings
o Exhibit 156: Sanofi SA – Segment focus
o 12.15 SGPharma Pvt. Ltd.
o Exhibit 157: SGPharma Pvt. Ltd. – Overview
o Exhibit 158: SGPharma Pvt. Ltd. – Product / Service
o Exhibit 159: SGPharma Pvt. Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Zydus Lifesciences Ltd.
o Exhibit 165: Zydus Lifesciences Ltd. – Overview
o Exhibit 166: Zydus Lifesciences Ltd. – Business segments
o Exhibit 167: Zydus Lifesciences Ltd. – Key offerings
o Exhibit 168: Zydus Lifesciences Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global infantile spasms therapeutics market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Route of Administration Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration – Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Parenteral – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Parenteral – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Parenteral – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Parenteral – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Oral – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Oral – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Oral – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Oral – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Drug Class – Market share 2023-2028 (%)
Exhibits45: Data Table on Drug Class – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Drug Class
Exhibits47: Data Table on Comparison by Drug Class
Exhibits48: Chart on Anticonvulsants – Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Anticonvulsants – Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Anticonvulsants – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Anticonvulsants – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Corticosteroids – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Corticosteroids – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Corticosteroids – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Corticosteroids – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Drug Class ($ million)
Exhibits61: Data Table on Market opportunity by Drug Class ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on France – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Amneal Pharmaceuticals Inc. – Overview
Exhibits112: Amneal Pharmaceuticals Inc. – Business segments
Exhibits113: Amneal Pharmaceuticals Inc. – Key news
Exhibits114: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits116: Cipla Ltd. – Overview
Exhibits117: Cipla Ltd. – Business segments
Exhibits118: Cipla Ltd. – Key news
Exhibits119: Cipla Ltd. – Key offerings
Exhibits120: Cipla Ltd. – Segment focus
Exhibits121: Endo International Plc – Overview
Exhibits122: Endo International Plc – Business segments
Exhibits123: Endo International Plc – Key news
Exhibits124: Endo International Plc – Key offerings
Exhibits125: Endo International Plc – Segment focus
Exhibits126: H Lundbeck AS – Overview
Exhibits127: H Lundbeck AS – Product / Service
Exhibits128: H Lundbeck AS – Key offerings
Exhibits129: Hetero Labs Ltd. – Overview
Exhibits130: Hetero Labs Ltd. – Product / Service
Exhibits131: Hetero Labs Ltd. – Key offerings
Exhibits132: Intas Pharmaceuticals Ltd. – Overview
Exhibits133: Intas Pharmaceuticals Ltd. – Product / Service
Exhibits134: Intas Pharmaceuticals Ltd. – Key offerings
Exhibits135: Jazz Pharmaceuticals Plc – Overview
Exhibits136: Jazz Pharmaceuticals Plc – Product / Service
Exhibits137: Jazz Pharmaceuticals Plc – Key news
Exhibits138: Jazz Pharmaceuticals Plc – Key offerings
Exhibits139: Mallinckrodt Plc – Overview
Exhibits140: Mallinckrodt Plc – Business segments
Exhibits141: Mallinckrodt Plc – Key offerings
Exhibits142: Mallinckrodt Plc – Segment focus
Exhibits143: Marinus Pharmaceuticals Inc. – Overview
Exhibits144: Marinus Pharmaceuticals Inc. – Product / Service
Exhibits145: Marinus Pharmaceuticals Inc. – Key offerings
Exhibits146: MSN Laboratories – Overview
Exhibits147: MSN Laboratories – Product / Service
Exhibits148: MSN Laboratories – Key offerings
Exhibits149: Ovid Therapeutics Inc. – Overview
Exhibits150: Ovid Therapeutics Inc. – Product / Service
Exhibits151: Ovid Therapeutics Inc. – Key offerings
Exhibits152: Sanofi SA – Overview
Exhibits153: Sanofi SA – Business segments
Exhibits154: Sanofi SA – Key news
Exhibits155: Sanofi SA – Key offerings
Exhibits156: Sanofi SA – Segment focus
Exhibits157: SGPharma Pvt. Ltd. – Overview
Exhibits158: SGPharma Pvt. Ltd. – Product / Service
Exhibits159: SGPharma Pvt. Ltd. – Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits165: Zydus Lifesciences Ltd. – Overview
Exhibits166: Zydus Lifesciences Ltd. – Business segments
Exhibits167: Zydus Lifesciences Ltd. – Key offerings
Exhibits168: Zydus Lifesciences Ltd. – Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations
